Sanofi Asserts 2nd Uroxatral Patent Against Sun
Sanofi-Aventis has hit Sun Pharmaceutical Industries Ltd. with another patent infringement suit over the drug Uroxatral, alleging that the generics maker infringed another of its patents for the prostate treatment....To view the full article, register now.
Already a subscriber? Click here to view full article